DULUTH, GA, March 5 /CNW/ - Stiefel Laboratories, Inc., the world's
largest independent pharmaceutical company specializing in dermatology,
announced today the appointment of Richard J. MacKay as Vice Chairman of the
Board of Directors. Mr. MacKay will retain the title of President, Stiefel
Canada, Inc. and continue to be involved in key areas of strategy, overall
guidance and relationships with Canadian dermatologists and industry partners.
In his new role, Mr. MacKay is charged with assessing the most important
issues that face the company in a global context and assisting the Board and
CEO on key projects and relationships. With 50 years in the Canadian
pharmaceutical industry, Mr. MacKay will draw on his considerable experience
and expertise to drive the company forward.
"Dick has been unstinting in his contribution to the growth and
development of Stiefel worldwide. He has demonstrated his talent for global
vision and shown exemplary leadership in a number of international executive
positions," said Charlie Stiefel, Chief Executive Officer and Chairman of the
Board, Stiefel Laboratories, Inc. "He is one of the key leaders in our
Mr. MacKay has been associated with Stiefel Laboratories and their
products for more than forty years. His innovation and management skills have
lead Stiefel Laboratories to become the leading dermatology company in Canada.
Throughout his career, Mr. MacKay has been active in many organizations
including the Board of the Canadian Dermatology Foundation where he has served
for the past 20 years. In 2003, Mr. Mackay was given the first ever Award of
Honour by the Canadian Dermatology Association for his service to the people
of Canada in raising the standards of health care.
About Stiefel Laboratories, Inc.
Founded in 1847, Stiefel Laboratories is the world's largest independent
pharmaceutical company specializing in dermatology. Its wholly-owned global
network is comprised of more than 30 subsidiaries, including manufacturing
plants in six countries, research and development facilities on four
continents and products marketed in more than 100 countries around the world.
The company manufactures and markets a variety of prescription and
non-prescription dermatological products. Some of the best-known brands in
Canada include PrCLINDOXYL(R) Gel, PrStieprox(R) Shampoo, PrNerisone(R) Cream,
IMPRUV(R) Cream and Uremol(R).
Stiefel Laboratories supplements its R&D efforts by aggressively seeking
acquisitions of dermatological product lines and companies around the world.
To learn more about Stiefel Laboratories, Inc., visit www.stiefel.com.
For further information:
For further information: Pierre Boucher, Executive Vice-President,
Stiefel Canada Inc., 6635 Henri-Bourassa Blvd. West, Montreal, Quebec, H4R
1E1, Phone: 1-800-363-2862, Fax: 1-800-561-1898, E-mail:
email@example.com, Web site: www.stiefel.ca